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Abstract
Total hip arthroplasty (THA) is a common procedure used to treat end-stage hip osteoarthritis
(OA). Various designs of implants are currently used to successfully perform these
procedures. However, the role of these design variations on early implant migration and
patient recovery is still being studied. In this study patients were prospectively randomized to
receive either a collared or collarless femoral stem. Differences were compared between
groups assessing implant migration, patient activity and patient functional differences.
Compared to the collarless femoral stem, it is believed that a collared femoral stem provides
improved axial stability early in the post-operative timeline. This study provides strong
evidence towards the improved stability of collared femoral stems within the first two weeks
post-operatively. This study also compares the implant groups and expresses an increase in
activity level early in recovery for patients receiving collared femoral stems.
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Chapter 1

1

Introduction

1.1 Osteoarthritis
Osteoarthritis (OA) is the most common form of arthritis in the world, mainly impacting
the weight bearing joints of the lower body [1]. OA is a degenerative joint disease
causing the gradual degradation of the joint cartilage over time. This leads to painful, stiff
and deformed joints resulting in an altered quality of life for the individual. As age and
obesity are major risk factors for OA, the economic impact of this disease continues to
rise [2].
OA is the single most common cause of disability in older adults [3]. Worldwide, adults
over the age of 60 have a 10-15% chance of having some degree of OA, with women
accounting for 55% of those affected [4,5]. The disease affects 10% of all Canadians
aged 15 or older [6,7]. In 2016-2017, 55,981 hip replacements were performed in
Canada, which is a 5-year increase of 17.8% [5]. The most common causes for requiring
a hip replacement were degenerative arthritis (81.2%) and acute hip fracture (15.1%) [5].
The burden of OA costs the Canadian government over $1 billion annually [5].

1.2 Hip Anatomy
The hip is one of the largest weight bearing joints of the body and can experience forces
up to five times an individual’s body weight [8]. The hip is a ball-and-socket joint. The
ball component of this joint is comprised of the femoral head and the socket is formed of
the acetabulum, which is part of the pelvis (Figure 1). The rounded head of the femur and
the concave acetabulum are covered in hyaline cartilage. This synovial joint is relatively
stable and has a large range of motion allowing for rotation (internal and external),
flexion, extension, abduction and adduction.
The acetabulum in contained within portions of the ilium, ischium and pubis (Figure 1). It
is cup shaped and positioned laterally within the pelvis bone allowing for femoral head
articulation. The acetabulum is rimmed with a fibrocartilaginous labrum which is an
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extension of the bony structure of the pelvis, deepening the socket (Figure 2). This
labrum functions to improve joint stability, seals synovial fluid in the joint capsule, acts
as a pressure distributor and as a shock absorber [9].
Further increasing the stability of the hip joint are the ligaments and muscles surrounding
the joint capsule. The iliofemoral, pubofemoral and ischiofemoral ligaments surround the
joint (Figure 3), along with the quadricep and gluteal muscles (Figure 4 and Figure 5).
These soft tissues work together to provide rotation, flexion, extension, abduction and
adduction of the hip joint.

Figure 1: Bony anatomy of the hip joint (AP view)
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Figure 2: Acetabular articular cartilage (Sagittal view)

Figure 3: Anterior hip ligaments
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Figure 4: Anterior hip muscles

Figure 5: Posterior hip muscles
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1.3 Total Hip Arthroplasty
Total hip arthroplasty (THA) is the procedure used to treat patients who have exhausted
non-surgical intervention to mitigate the debilitating pain and limited range of motion
(ROM) they are experiencing. The first repeatably successful THA procedure was
developed in the 1960’s by Sir John Charnley [10]. This procedure can be used to treat
many hip related diseases including OA, rheumatoid arthritis, and bone fractures.
THA is the accepted procedure for patients with OA of the hip [11]. This procedure is
very successful, with more than 90% of patients experiencing pain relief [12]. The most
significant decrease in pain and function is experienced within the first three months
post-operatively [12].
The longevity of a joint replacement is important as the population is aging and expecting
implants to last longer. Implants that ultimately fail require revision. According to the
Canadian Joint Replacement Registry Annual Report, in 2016-2017 there were 4,664 hip
revisions performed representing 8.6% of all THA procedures conducted that year [13].
As THA procedures are performed on patients of all ages, it is important to understand
the risks associated with undergoing the procedure earlier in life. Bayliss et al. found that
the 10-year survival rate for THA procedures was 95.6% among all age groups [14].
When categorizing patients older and younger than 70 years, this study found that there
was a 5% risk of revision in their lifetime for older patients and a 35% risk of revision in
their lifetime for younger patients [14]. There are many reasons for THA revisions
including pre-operative patient demographic, clinical factors and surgical factors.
Patients demand shorter recovery times and increased activity earlier post-operatively,
adding pressure to implement rapid recovery care pathways. The combination of patient
input and cost savings using these pathways are pushing for new ways to conduct THA
procedures to solve these challenges. Rapid recovery care and outpatient procedures
appear to be this solution. In order to facilitate this, focus needs to be put on surgical
changes leading to a decrease in post-operative pain, ultimately resulting in shorter
recovery times and more patient activity. These procedural changes could drastically
reduce inpatient care for most primary THA patients. The increasing adaptation of the
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direct anterior (DA) surgical approach compared to other THA surgical approaches has
demonstrated earlier function, less pain and shorter recovery times [15]. Another key
aspect of these procedures is the implementation of new surgical instrumentation that
orthopaedic partners are providing. The combination of new equipment and surgical
approaches which further improve patient recovery are working towards providing a
solution to the rapid recovery pressures.

1.4 Surgical Approaches for THA
During the THA procedure, the damaged femoral and acetabular surfaces are removed
and replaced with a metal stem placed into the centre of the femur and a metal socket
placed in the acetabulum of the pelvis. A metal or ceramic head is placed on the femoral
stem, replacing the arthritic femoral head. A liner is placed within the cup allowing for a
smooth articulating interface for the femoral head [16].
A key component of preoperative planning for the THA procedure is selecting the
surgical approach to be used. This decision can be influenced by surgeon preference,
previous incisions, obesity, risk for dislocation, implant selection, or level of deformity.
The surgical approach used should provide appropriate access to the joint capsule while
minimizing the risk to neurovascular structures and limit soft tissue damage.

1.4.1

Direct Anterior

The DA surgical approach was first described by Hueter in 1881 [17]. This approach is
geared towards rapid recovery care [18–20]. It requires the patient to be placed in a
supine or lateral decubitus position allowing for an anterior approach to be used (Figure
6). Although the procedure can be performed on a normal operating table without
imaging, many surgeons prefer a specialized table with fluoroscopy allowing them to
gain better visibility of the joint (Figure 7). These specialized tables allow individual
control of each limb, providing traction, rotation and angulation [21].
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Figure 6: Direct anterior approach (Lateral view)
There are many advantages to the DA approach. This procedure is considered a muscle
sparing and inter-nervous approach [21]. It provides an early recovery with greater
patient activity and decreased surgical pain. Patients that receive this procedure also
experience a low hip joint dislocation rate [22]. The great benefits of this procedure do
come at a cost. This is a challenging procedure that surgeons experience a steep learning
curve to master [23]. It can be more difficult to achieve proper femoral exposure and
femoral preparation in the DA approach resulting in an increased risk of malalignment,
under sizing the implant or ultimately aseptic loosening [24,25]. It is believed that using a
collared femoral stem can help mitigate the risk of aseptic loosening and fracture by
providing improved immediate stability of the implant along with providing the surgeon
with the confidence that they can more precisely control leg length during THA
procedures when the collar abuts the calcar of the femur [26,27].
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Figure 7: Traction table setup used for DA THA

1.4.2

Direct Lateral

The modern direct lateral (DL) surgical approach was described by Hardinge in 1982 and
is the most common procedure in Canada with more than 60% of orthopaedic surgeons
using this approach [28,29]. The DL approach provides excellent exposure of both the
proximal femur and the acetabulum. This procedure requires the patient to be in a lateral
or supine (distinct minority) position on the table and is able to be conducted using a
normal operating table with a patient positioning device to hold the pelvis in place during
the procedure (Figure 8).
The greater proximal femur exposure during the DL approach allows for easier
component positioning. The avoidance of major nerves during this operation reduces the
risk of excess damage as well. Similar to the DA approach, the DL approach is known for
low dislocation rates [30]. This procedure does have disadvantages to it as well. The joint
capsule exposure comes at the cost of an increase in damage to the muscles used during
abduction. If the procedure is conducted unilaterally, it may result in asymmetry between
legs and can result in abnormal gait that may be experienced long after recovery [31].
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Figure 8: Direct lateral approach (Posterior view)

1.4.3

Direct Posterior

In the 1950s Moore made the direct posterior (DP) approach popular [32]. The DP
approach provides excellent acetabular and femoral exposure. This procedure requires the
patient to be positioned laterally on a normal operating table while using a patient
positioning device to stabilize the pelvis during the procedure (Figure 9). Worldwide this
procedure is most commonly used, while in Canada it is used about one-third of the time
[29,33].
The main advantage of the DP approach is not splitting the gluteus medius that leads to
the post-operative limp after the DL approach. Another advantage is the reduced risk of
nerve damage that the DA approach brings with it. These advantages come at the cost of
an increase in dislocation risk.

10

Figure 9: Direct posterior approach (Posterior view)

1.5 Implant Design
There are four main components of hip implants: the cup, the head, the stem and the
liner. The cup is fixed to the acetabulum, the stem is inserted into the femur and the head
is attached to the end of the stem allowing for smooth contact between the cup and the
stem. There are two ways of fixing the stem into the femur: cemented and uncemented.
The best fixation method for primary THA procedures continues to be debated and the
longevity of the THA depends on the mechanical integrity of the implant-bone bond [34].
If this bond happens to be damaged, there may be relative motion resulting in a failed
THA. Cemented implants have two interfaces, implant-cement and cement-bone, and is
believed to provide immediate fixation of the implant (Figure 10). Although this provides
a benefit in the short term, some view it as a concern in young and more active patients as
dynamic loading of the hip joint may cause micro cracks in the cement resulting in
relative motion of the implant and gradual debonding from the cement [35]. Uncemented
implants are press-fit into the bone, relying on biological fixation to ensure long-term
survival of the implant (Figure 10) [36]. Although both cemented and uncemented
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femoral fixation are used worldwide, North America mainly uses uncemented femoral
fixation as the primary method for THA procedures [37].
Beyond fixation methods, the specific design of the implant may have an impact on the
replacement longevity. Hip implants have undergone many design revisions while
striving for the best solution and long-term survivorship. For an uncemented stem to
obtain adequate biological fixation, motion between the implant and bone should be
minimized. A solution to this problem has been attempted by adding a collar to the pressfit hydroxyapatite coated stems, preventing implant subsidence by providing better
immediate stability (Figure 11) [27].

Figure 10: Uncemented and cemented femoral components
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Figure 11: Collared and collarless femoral implants
Recent literature has identified greater amounts of subsidence for collarless stems leading
to loosening, instability and periprosthetic fracture [38–42]. The increasing pressure for
rapid recovery care is pushing patients, and their implants, to provide better stability
earlier on. The femoral stem collar improves the immediate stability, provides greater
resistance to subsidence and reduces the risk of early micromotion ultimately allowing
better implant biological fixation [27,38]. The goal is to maintain the stem’s initial
intraoperative position, decrease the amount of subsidence, and achieve accurate patient
leg length. This is accomplished by inserting the implant such that the collar rests on the
calcar (Figure 12).
Improper collar-calcar contact exposes the limitations that a collared femoral stem has
compared to a collarless femoral stem. Uneven stress distributions between the collar and
calcar can lead to implant subsidence and rotation of the collared implant (Figure 13)
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[43,44]. The stress shielding a collar provides if improperly inserted can lead to implant
loosening and failure through repetitive loading [45].

Figure 12: Femoral component illustrating proper immediate collar-calcar contact

Figure 13: Collared implant illustrating excess varus rotation
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1.6 Radiostereometric Analysis
Implant fixation is important when assessing the success of a THA procedure [46,47]. To
analyze implant stability throughout recovery, surgeons measure the relative implant
positioning between patient follow-up visits. Using biological and component landmarks,
the relative motion of the implant to the bone is measurable. A limitation of using
biological landmarks and clinical x-rays is the lack of leg positioning uniformity between
visits leading to less accurate measurements. It is reported that a migration of at least 2
mm is necessary before any migration can be determined [48].
In order to ensure measurement accuracy between visits, a stereo x-ray technique called
radiostereometric analysis (RSA) is used. This stereo x-ray technique used to image a
single object on two films provides the necessary information required to extract the
three-dimensional location of the object in space. Knowing where both the x-ray sources
and detectors are positioned relative to each other and tracing a line between the
projected image to the sources, provides the location of the object in space being the
intersection of the lines (Figure 14).

Figure 14: Three-dimensional object location reconstruction using stereo x-rays
Modern RSA techniques, explained by Selvik, use the same theory to measure
component locations in space [49]. Rather than using a set apparatus with known
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distances between sources and films, it now uses a cage with control and fiducial beads to
calculate the relative location of the sources and detectors (Figure 15). This is an
extremely accurate measurement technique used to help surgeons monitor implant
migrations throughout recovery. Modern RSA can be as precise as hundreds of microns
for translation and half a degree for rotation [50]. It is based on the assumption that the
components and environment are made up of rigid bodies. A rigid body is a solid body
with zero deformity, or deformity so small that it can be considered negligible. When
using markers, this rigid body can be understood as the distance between any two
markers on the rigid body remaining constant over time. If any of these distances
between markers change over time, it is assumed that the body has become deformed.

Figure 15: Uniplanar RSA calibration cage
In RSA the translation and rotations are measured between rigid bodies. When analyzing
the motion of the implant relative to the bone, a rigid body is assigned to the implant and
another is assigned to the bone. As biological landmarks are difficult to consistently and
accurately identify in all radiographs, markers are injected into the cortical bone
surrounding the implant. These markers are radiolucent tantalum beads that remain fixed
and stationary in the bone.
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In order to create a rigid body for the bone, a minimum of three non-colinear beads are
required [51]. As an inherent limitation of x-rays, some beads may not be visible due to
the variation in limb internal/external rotation that would block the beads with the
implant components. In order to compensate for unmeasurable beads, between five and
nine beads are inserted into the bone to form the rigid body. The accuracy of the RSA
measurements is not only dependent on the number of beads and their stability, but also
their spread. It is important to have a large distance between the beads as well as a good
distribution of these beads in all three axes [50]. The more colinear the beads are inserted,
the lower the measurement accuracy will be (Figure 16) [52].

Figure 16: X-ray illustrating tantalum bead placement in the femur around the
implant (the red arrows are pointing to the beads)
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Creating the rigid body for the component can be done in two ways. Using a markerbased method, beads are embedded in the implant prior to fixation. This comes with the
limitation of beads being undetectable as a result of imaging angles. This disadvantage
can be resolved using a model-based method. A three-dimensional model of the implant
is created, and using specific model-based RSA software, the digital implant model can
be fit to the radiographs and represent the rigid body of the component (Figure 17) [53].

Figure 17: Model based RSA software illustrating the projection
of the implant onto stereo radiographs
Taking into account the rigid body of the bone, comprised of markers, and the rigid body
of the component, from the digital implant model, the relative location of the component
to the bone can be recorded. A standardized component coordinate system aligned with
the longitudinal axis of the stem as well as the geometric centre of the y-position is used
to repeatably measure implant positioning. Obtaining multiple RSA images throughout
the recovery process allows for implant migration tracking. RSA provides us with the
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ability to measure implant migration early post-operatively, long before anything would
manifest clinically which provides us with the ability to predict implant success. Studies
have shown that early implant subsidence is an indicator for late aseptic loosening
[54,55].

1.7 Wearables
The main goal of THA is to eliminate OA pain and improve patients’ quality of life
[56,57]. There are different ways to measure patient activity, including subjective patient
diaries, self-reported scores and objective testing. Objective testing can provide more
accurate insight as patients tend to over- or under-estimate their activity when selfreporting [58,59]. Function can be measured using a series of standardized tests and
activity can be measured using wearable trackers. Wearable trackers are light and easy to
use devices that measure an individual’s activity and functional levels. These
technologies have been successfully used to monitor physical activity levels in THA
patients [60].

1.7.1

Function

Functional tests are used to assess THA patients clinically. These tests are used to
represent daily mobility while in clinic. Common functional tests include the timed-upand-go (TUG) test and the 6-minute walk test (6MWT) [61]. The TUG test originated as
a risk assessment for falls, categorizing patients based on their time to complete the entire
test. Patients are asked to start in a seated position, stand up and walk to a marker three
metres away, turn around at the marker and walk back to the chair to sit. This test uses a
threshold of 14 seconds to complete the entire test to classify if patients are at a high risk
for falls or not, where lower times indicate greater functional ability [62]. The 6MWT is
used to assess an individual’s aerobic and endurance capacity. The total distance walked
in six minutes is used to compare patient performance. Markers are placed 30 metres
apart and patients are asked to walk to and from the markers for the entire six-minute
period. It has been studied that a minimum difference of 2.27 seconds for the TUG test
and 45 metres travelled for the 6MWT is required to determine a real change in patient
performance during different tests [63,64].
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The TUG test is an assessment of function as it compares all aspects of mobility
including standing, sitting, walking and turning in a short distance over a short period of
time in a controlled environment [65]. As the TUG test only takes into account the
temporal component, it can be further analyzed using inertial sensors [66]. Patients may
impart different strategies to complete the test and result in the same amount of time
passed, ultimately expressing no difference in function. Using inertial sensors provides
insight into the gait analysis of this functional test highlighting the strategies patients use.
A patient with a limp that completes the TUG test in the same amount of time as a
healthy patient will express no difference temporally. When adding in the analysis of
their gait, the variation between individuals is measured. Test times are good at
predicting function, but it does not give the full information of the patient’s recovery
[67].

1.7.2

Activity

Wearable activity trackers are readily available tools used to measure patient activity.
These trackers use accelerometers to measure an individual’s daily step counts, intensity
of their activity, and calories burned throughout the day [68]. Studies have analyzed the
relationship between patient activity to step counts, as well as patient activity to
functional recovery [69,70]. A variety of wrist-worn wearable trackers are validated and
reliably used to measure an individual’s activity [71]. The availability of these trackers
makes it an obvious metric to analyze for patients undergoing a THA procedure. As full
recovery from THA procedures has been shown to last as long as four years, tracking the
recovery and comparing activity to pre-operative results can show insight into an
individual’s activity changes [72].

1.8 Patient Reported Outcome Measures
Patient reported outcome measures (PROMs) use a series of questionnaires to quantify
patient qualities such as pain and function. It allows the patient to provide direct feedback
on their care. PROMs are generic and disease specific tools used frequently in clinics to
assess patients’ pre- and post-operative health. The Short Form 12 (SF-12), the Western
Ontario and McMaster Universities Osteoarthritis Index (WOMAC), the Harris Hip
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Score (HHS) and the University of California, Los Angeles (UCLA) activity score
questionnaires are commonly used in orthopaedic clinics to measure general mental and
physical wellbeing, lower limb function with respect to OA, patient activity and THA
specific functional outcomes respectively. The SF-12 is a measure of a patients mental
and physical wellbeing. The WOMAC is widely used to evaluate the condition of patients
with hip OA and uses a set of five items to measure pain, two for stiffness, and 17 for
functional limitation. The HHS is specifically designed for assessing patients undergoing
hip surgery and consists of 10 items assessing pain, function, absence of deformity, and
range of motion. The UCLA activity score is a general PROM with a 10-item scale
ranging all activity levels.
PROMs provide a simple insight into an individual’s THA procedure, but this insight
comes with limitations [73]. A limiting factor of PROMs is their vulnerability to bias and
ceiling or floor effects [74–76]. A patient’s individual expectations can influence the
outcomes of these questionnaires due to the drastic improvements patients experience
from this procedure [77].

1.9 Thesis Objectives and Hypothesis
Given the increasing demand for rapid recovery care pathways, there is an increase in
enhanced recovery care pathway surgeries and a decrease in time away from patient
activities. To facilitate rapid recovery care pathways, orthopaedic industry partners are
adapting their designs to potentially help reduce the recovery time. The objectives of this
thesis are to: 1) determine the impact implant design has on femoral stem fixation, and 2)
understand the role implant design has on patient activity and function early on following
a THA procedure. We hypothesize that the collared femoral stem will result in less
implant migration and a quicker recovery than patients who receive the collarless femoral
stem.
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Chapter 2

2

Determining the Early Impact Implant Design has on
Implant Migration Following Total Hip Arthroplasty

2.1 Introduction
Arthritis, most commonly osteoarthritis (OA) and rheumatoid arthritis (RA), is a disease
that affects the joints of the body. OA is a degenerative disease that affects the load
bearing joints, whereas RA is an autoimmune disease that can impact any joint. Patients
who suffer from end-stage hip OA elect to undergo a total hip arthroplasty (THA). This
common orthopaedic procedure has been reported as one of the most successful and
reliable procedures today with an 86% success rate at 15 years [1]. Not only is it an
extremely successful procedure, but it is among the most common elective surgeries
performed in Canada with over 50,000 conducted annually and this number is expected to
rise [2]. Diagnosis of hip OA is determined through radiography, patient history and
physical assessment. Although the majority of patients are between 60-80 years of age,
there is no specific age when an individual would require a THA [3].
Different surgical approaches can be used for primary THA procedures with each one
having its own inherent advantages and disadvantages. The direct anterior (DA) approach
has recently gained traction due to its muscle sparing nature. As there is a push for rapid
recovery care pathways, the reduction in recovery time as a result of inter-nervous and
inter-muscular approach is beneficial [4–6]. The DA approach comes with the benefit of
faster recovery, reduced pain post-operatively, reduced length of hospital stay and a
quicker return to daily activities [7–10]. A downside of the DA approach is the steep
learning curve associated with this procedure that may impact the complication and
failure rate. The limited field-of-view may also add to this concern by making it more
difficult to insert standard femoral stems [11]. Rivera et al found that the DA approach
can lead to a three-times higher likelihood of using an undersized stem when compared to
other surgical approaches [11]. The difficulty in femoral preparation and the potential
complications could lead to this under sizing and ultimately increased migration [11].
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It is important to understand the impact the DA approach has on implant migration as
early migration can be an indicator of an early risk of revision in the future [12].
Subsidence of THA components is a natural occurrence throughout recovery as a result
of the net forces during normal ambulation [13]. There are many implant designs
available to surgeons including cemented and cementless femoral stems [14]. Implant
design has evolved to help mitigate the problems rising from migration. It is important to
analyze new implant designs as these novel implants may not be better than their
predecessors [15]. Some studies have shown that there is reduced implant migration with
axial loading when there is proper collar seating [16,17]. It is important to investigate the
implant migration clinically to determine the success of the new design.
Clinical x-rays require a minimum subsidence of 2 mm before any migration can be
determined [18]. In order to measure the migration between implants more accurately,
radiostereometric analysis (RSA) is used, ultimately leading to the prediction of
loosening [19,20]. RSA allows accurate measurements of three-dimensional objects and
compares relative motion between them [21]. RSA has been shown to be the most
accurate method of measuring in-vivo implant migration [22]. Subsidence of 2.7 mm or
more in the first two years for cementless femoral stems have shown to be associated
with an increase in the risk of revision due to aseptic loosening [23]. This risk makes it
important to measure the early migration of each implant design.
The purpose of this study was to measure the early implant migrations of collared and
collarless femoral stems for patients undergoing the DA surgical approach. We
hypothesized that patients receiving the collared femoral stem will experience less
implant migration than those who receive the collarless femoral stem.

2.2 Methods
After obtaining research ethics board approval, patients were enrolled pre-operatively
between January 2018 and February 2019. Patients with unilateral hip OA who were
undergoing a primary THA procedure were eligible to participate in this prospective
randomized clinical trial. This study was powered for RSA, allowing for early migration
measurements of the orthopaedic implants. A recent RSA study measuring migration of
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the collarless Corail stem found a mean subsidence of 0.58 mm at two years with a
standard deviation of 0.91 mm [24]. Using a paired t-test to compare subsidence between
the collared and collarless groups, with alpha = 0.05, power = 0.8, n = 18 (allowing for a
20% drop out), and assuming an SD of 0.91 mm, we will detect differences between
groups of 0.63 mm or greater [25]. Assuming we will observe the same mean subsidence
as Campbell et al, a difference of 0.63 mm would be a subsidence of 1.21 mm which is
above the threshold indicating a high risk of early loosening requiring revision [24,25].

2.2.1

Inclusion and Exclusion Criteria

Patients included in this study were undergoing a primary THA procedure diagnosed with
unilateral hip OA. Exclusion criteria included a BMI greater than 40, symptomatic
contralateral OA, bilateral or revision THA procedures, cognitive defects or
neuromuscular disorders that would prevent a walking test, the inability to understand
English and if the patient lived more than 100 km from our research centre in London,
Ontario.

2.2.2

Surgical Intervention

Patients were referred to the University Hospital, London Health Sciences Centre. Those
who were undergoing the DA surgical approach were randomly selected pre-operatively
to either receive a collared or a collarless Depuy Corail femoral stem (Figure 18). A
block randomization with concealed envelopes was used to assign participants to either
implant.

2.2.3

Analysis Follow-Up

To enable RSA analysis, a minimum of six 1 mm diameter tantalum beads were inserted
into the proximal cortical bone of the femur intraoperatively. A baseline RSA exam was
conducted within the first 24 hours post-operatively, before the patient was discharged
from the hospital. Each patient received an RSA exam at follow-up visits to the hospital
(two-, four-, six-weeks and three months). All RSA exams were conducted with the
patient in a supine position over a uniplanar calibration cage (RSA Biomedical, Umea,
Sweden) to ensure no weightbearing forces are imparted on the hip joint. The radiographs
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were analyzed using commercial model-based RSA software (RSAcore, Leiden, The
Netherlands). Positive translation directions are defined as proximal translation, y-axis,
medial translation, x-axis, and anterior translation, z-axis. Positive rotation directions are
defined as internal rotation, about the y-axis, valgus rotation, about the z-axis, and
anterior tilt, about the x-axis. Cumulative implant migrations were determined using the
24 hour as well as the two week RSA exams to illustrate the changes starting within 24
hours post-operatively as well as from two weeks onwards. Individual patient cases were
identified that illustrated different implant migration patterns compared to the average
among implants within their group.

2.2.4

Patient Reported Outcome Measure Follow-Up

Demographics such as height, weight and age were collected pre-operatively (Table 1).
The Short Form 12 (SF-12) along with the University of California, Los Angeles (UCLA)
activity score, the Western Ontario and McMaster Universities Arthritis Index
(WOMAC) and the Harris Hip Score (HHS) were also collected from each patient preoperatively and at three months post-operatively.
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Assessed for eligibility (n=190)

Ineligible (n=77)
Lives more than 100km from London, ON (n=49)
BMI > 40 (n=5)
Contralateral symptomatic OA (n=9)
THA not due to OA (n=4)
Planned to undergo DL approach (n=5)
Cognitive issues (n=1)
Knee OA (n=1)
Recruited into a different study (n=1)
Bad bone quality (n=1)

Approached in Pre-Admission
Clinic (n=113)
Ineligible (n=65)
Did not meet (n=23)
Did not successfully recruit (n=42)

Randomized (n=48)

Collared (n=24)

Allocation

Received allocated intervention (n=19)
Did not receive allocated intervention (n=5)

Received allocated intervention (n=23)
Did not receive allocated intervention (n=1)

Different stem (n=2)
Withdrew prior to surgery (n=3)

Collared (n=14)

Collarless (n=24)

Withdrew prior to surgery (n=1)

3 Month
Follow-Up

Collarless (n=15)

Figure 18: Participant flow through the study

2.2.5

Statistical Analysis

Demographics, patient reported outcome measures (PROMs) and RSA migrations were
reported with descriptive statistics including means, standard deviations and ranges. Data
was tested to be normal or not to determine which statistical tests were appropriate.
Demographics between groups were compared using unpaired t-tests, while the ratios of
male:female and right:left hip were compared using a Fisher’s exact test. To compare the
migration of the collared implant to the collarless implant a 2-way ANOVA was used.
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The outcome scores were compared between groups using Mann-Whitney tests. All
statistical tests were conducted using GraphPad Prism version 8.

2.3 Results
2.3.1

Demographics

There were no significant differences in patient demographics (Table 1), SF-12,
WOMAC, HHS or UCLA outcome measures (Table 2) between the implant groups.
Table 1: Patient demographics for the two implant groups, presented as mean ±
standard deviations (where applicable)
Characteristic
Age at surgery (years)
Patient sex
Surgical side
Height (m)
Weight (kg)
BMI (kg/m2)

Collared

Collarless

p value

64.6 ± 8.7
12 Male, 7 Female
12 Left, 7 Right
1.75 ± 0.08
88.69 ± 18.44
28.80 ± 5.1

65.0 ± 8.1
12 Male, 11 Female
9 Left, 14 Right
1.73 ± 0.11
91.31 ± 20.83
30.35 ± 4.89

0.872
0.542
0.214
0.393
0.672
0.321
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Table 2: Clinical outcome scores, presented as mean ± standard deviation, minimum
and maximum values
Outcome Measure
SF-12 MCS
Pre-Operation
3 Months

Collared

Collarless

55.15 ± 9.17
(36.52 to 66.40)
58.17 ± 3.35
(52.96 to 62.97)

57.28 ± 5.96
(45.84 to 65.73)
58.16 ± 4.35
(51.16 to 61.97)

36.64 ± 10.88
(23.79 to 57.29)
49.80 ± 5.29
(39.27 to 55.50)

30.65 ± 8.81
(20.44 to 46.86)
43.08 ± 10.64
(28.49 to 55.26)

52.67 ± 13.24
(28.09 to 86.16)
88.64 ± 6.28
(80.78 to 100.0)

47.31 ± 18.95
(15.94 to 77.27)
77.79 ± 18.00
(51.11 to 100.0)

62.44 ± 7.81
(45.00 to 75.00)
98.33 ± 2.88
(93.00 to 100.0)

55.88 ± 10.33
(39.00 to 73.00)
96.80 ± 4.43
(91.00 to 100.0)

5.53 ± 1.65
(3 to 8)
6.86 ± 1.41
(4 to 9)

5.22 ± 1.78
(2 to 6)
6.47 ± 1.51
(4 to 8)

0.16 ± 0.50
(0 to 2)

0.39 ± 0.66
(0 to 2)

p value
0.431
0.370

SF-12 PCS
Pre-Operation
3 Months

0.091
0.142

WOMAC Total
Pre-Operation
3 Months

0.356
0.077

HHS Total
Pre-Operation
3 Months

0.188
0.220

UCLA
Pre-Operation
3 Months

0.566
0.478

Comorbidity Index
Pre-Operation

0.167

37

2.3.2

Radiostereometric Analysis – 24 Hour Baseline

The average migrations and rotations for collared and collarless femoral stems using an
RSA examination baseline within 24 hours post-operatively are shown in Figure 19. The
collarless group demonstrated significantly greater subsidence (negative proximal
migration) at two weeks than the collared group (mean difference = 2.90 mm, p = 0.005).
The collarless group also demonstrated significantly greater anterior tilt at two weeks
than the collared group (mean difference = 0.55°, p = 0.002). There was no significant
difference at two weeks between groups for medial-lateral translation (mean difference =
0.34 mm, p = 0.190), posterior-anterior translation (mean difference = 0.35 mm,
p=0.069), valgus rotation (mean difference = 0.58°, p = 0.181) or internal rotation (mean
difference = 1.08°, p = 0.281).
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Figure 19: Line graphs showing the average migration in all planes across three
months (12 weeks) using a baseline within 24 hours post-operatively. A) Subsidence
in the coronal plane; B) internal rotation about the coronal plane; C) lateral-medial
translation in the axial plane; D) anterior tilt about the axial plane; E) posterioranterior translation in the sagittal plane; F) valgus rotation about the sagittal plane.
Significant differences are represented using an ‘*’ (p<0.05)
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2.3.3

Radiostereometric Analysis – 2 Week Baseline

The average migrations and rotations for collared and collarless femoral stems using an
RSA examination baseline at two weeks post-operatively are shown in Figure 20. There
was no significant difference between groups at three months for subsidence (mean
difference = 0.21 mm, p = 0.831), medial-lateral translation (mean difference = 0.16 mm,
p = 0.183), posterior-anterior translation (mean difference = 0.19 mm, p = 0.137), internal
rotation (mean difference = 0.11°, p = 0.458), anterior tilt (mean difference = 0.17°, p =
0.722) or valgus rotation (mean difference = 0.12°, p = 0.583).

40

B

Proximal Migration (Ty)
1.5

Collared

1.0

Collarless
Rotation (°)

Translation (mm)

A

0.5
0.0
-0.5
-1.0
-1.5

2

4

6

Internal Rotation (Ry)
2

0
-1

2

Weeks Following Surgery

D

Medial Migration (Tx)
1.5

Collared

1.0

Collarless

0.5
0.0
-0.5
-1.0
-1.5

2

4

6

2

Collared

1.0

F

Collarless

0.5
0.0
-0.5
-1.0
-1.5

2

4

6

Weeks Following Surgery

Collarless

0
-1

2

4

6

12

Weeks Following Surgery

Rotation (°)

Translation (mm)

Collared

12

1

-2

12

Anterior Migration (Tz)
1.5

6

Anterior Tilt (Rx)

Weeks Following Surgery

E

4

Weeks Following Surgery

Rotation (°)

Translation (mm)

C

Collarless

1

-2

12

Collared

12

Valgus Rotation (Rz)
2

Collared

Collarless

1
0
-1
-2

2

4

6

12

Weeks Following Surgery

Figure 20: Line graphs showing the average migration in all planes across three
months (12 weeks) using a baseline two weeks post-operatively. A) Subsidence in the
coronal plane; B) internal rotation about the coronal plane; C) lateral-medial
translation in the axial plane; D) anterior tilt about the axial plane; E) posterioranterior translation in the sagittal plane; F) valgus rotation about the sagittal plane
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2.3.4

Case Studies

Patients with substantial femoral stem migrations are described in Table 3 and shown in
Figure 21.
Table 3: Patient demographics and implant used for the three patient cases,
presented as patient specific metrics
Characteristic
Age (years)
Sex (M/F)
Surgical side
Height (m)
Weight (kg)
BMI (kg/m2)
Implant

A (Collared)
62
M
L
1.89
98.4
27.6
Size 16 High-Offset

B (Collarless)
85
F
L
1.58
54.9
22.0
Size 12 Standard

C (Collarless)
69
F
R
1.68
72
25.7
Size 9 Standard

Patient A received a collared stem and demonstrated a consistent rate of subsidence up to
7.52 mm at six weeks, which then slowed with an increase to 8.61 mm at 12 weeks. This
patient experienced external rotation of their implant of 4.64° at two weeks, which then
slowed approaching four weeks with an increase to 4.96°, and at six weeks their implant
rotated internally ending up at 1.81° of external rotation. This patient’s implant followed
the same valgus rotational trend that other patients with collared stems did.
Patient B received a collarless stem and demonstrated a large amount subsidence in the
first two weeks of 11.12 mm which gradually increased to 11.46 mm at 12 weeks. This
patient, similar to the average patients that received collarless stems, experienced external
rotation. Their implant initially externally rotated 1.94° in the first two weeks, then
rotating internally approaching 12 weeks, resulting in 0.71° of external rotation.
Similarly, this patient’s implant initially experienced a valgus rotation of 2.14° at two
weeks, slowly approaching 2.29° of valgus rotation at 12 weeks.
Patient C received a collarless stem and also demonstrated a large amount of subsidence
in the first two weeks of 11.49 mm which gradually increased to 13.01 mm at 12 weeks.
This patient, unlike the average patients receiving collarless implants, experienced
internal rotation. Their implant initially rotated 0.50° in the first two weeks, and
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continued to internally rotate, reaching 3.66° at 12 weeks. This patient’s implant
experienced excess valgus rotation in the first two weeks of 4.48° which slowed
approaching 12 weeks resulting in 4.80° of valgus rotation.
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Figure 21: Line graphs showing migration patterns of selected cases for collared and
collarless implants over three months (12 weeks). A) subsidence, B) internal rotation
and C) valgus rotation for patient A compared to the collared mean; D) subsidence,
E) internal rotation and F) valgus rotation for patients B and C compared to the
collarless mean; G) visualization of patient A’s implant migration over three
months; H) visualization of patient implant B’s migration over three months; I)
visualization of patient C’s implant migration over three months
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2.4 Discussion
The aim of this study was to measure the early migration patterns for collared and
collarless femoral stems in patients undergoing the DA approach. It has been shown that
RSA is the preferred tool for measuring implant fixation [19]. Studies have evaluated
early migration using clinical x-rays assessing migrations starting on the day of
discharge, but these are unable to assess migrations to the precision required to determine
relevant variations. Studies have evaluated early migration using RSA, but these have
used baseline images taken after multiple weightbearing days, omitting the crucial
migration information occurring immediately post-operatively [24,26]. This study is the
first to measure the Corail stem migration using a baseline RSA exam within 24 hours
post-operatively and assessing implant migration throughout the early recovery period.
The Corail femoral stem was first introduced in 1986, and with refinements over the
years, has been proven to last with 96.17% survival for collarless stems and 97.66%
survival for collared stems at 10 years [27]. Although femoral stems have a good survival
rate, studies have found that early migration is an indicator for an increased risk of
revision in the future [12,23–25,28–33]. Initial subsidence ultimately plateaus once
mechanical stability is reached. The majority of osseointegration occurs within the first
three months but has been reported to take up to three years in some cases [34,35]. This is
the reason why it is most important to ensure stability early on in the first three months to
guarantee good long-term fixation.
Campbell et al [24] assessed 30 patients that received the cementless Corail collarless
femoral stem and obtained RSA radiographs throughout recovery at six months, one- and
two-years using a baseline of three- or four-days post-operation. They observed a mean
subsidence of 0.73 mm at six months with minimal subsidence thereafter. Strom et al [26]
assessed 29 patients that received the cementless CLS collarless femoral stem, which has
a tapered neck geometry similar to the Corail stem. They obtained RSA radiographs
throughout recovery at one day, one week and three months using a baseline x-ray
immediately post-operation. They saw a mean subsidence of 0.69 mm (unrestricted
weightbearing) and 0.47 mm (partial weightbearing) at three months with minimal
migration thereafter. We obtained follow-up radiographs throughout recovery at two-,
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four-, six-weeks and three months using a baseline within 24 hours post-operation. The
majority of the subsidence in our study occurred within the first two weeks. We observed
larger subsidence in the first two weeks for both collared and collarless implants that
other studies saw in their early timeframes. By taking many follow-up images within
three months, we are able to determine when during early recovery the stems become
stabilized, whereas other studies focussed on the migrations experienced over longer
periods of time.
Using a baseline RSA exam within 24 hours post-operation with early follow-ups, we
were able to observe the migration patterns early in recovery. It was not possible to
obtain RSA radiographs intraoperatively as the calibrated equipment required is not
accessible in the operating room. There is a greater force required to induce subsidence in
a collared femoral stem compared to a collarless one [17]. If the collared femoral stem is
inserted with the collar resting properly on the calcar during the procedure, then the
forces leading to subsidence will be supported by the collar, maintaining the implant’s
initial position [17,36]. Our data supports the literature and demonstrates that within the
first two weeks post-operation the collarless femoral stem subsided significantly more
than the collared femoral stem. A striking feature of our study is the amount of femoral
stem subsidence observed within the first two weeks that plateaus thereafter. During the
first two weeks, collarless femoral stems subsided a mean of 3.80 ± 3.37 mm while
collared femoral stems subsided a mean of 0.90 ± 1.20 mm. Between two weeks and
three months, the stems only subside an additional 0.46 ± 0.46 mm for collarless stems
and 0.67 ± 1.61 mm for collared stems (Figure 20). This lends support to the idea that
once the collar rests on the calcar, it results in improved stability and fixation allowing
better biological fixation.
Our data demonstrates that collared femoral stems rotated externally 1.40° and collarless
femoral stems rotated externally 2.48° within the first two weeks. This rotation stabilized
after the second week and only rotated an additional 0.36° for the collared implant and an
additional 0.22° for the collarless implant. Other studies have observed internal and
external rotations that were similar to what we observed from two weeks to three months
during their baseline to initial follow-up images. This leads us to believe that we are
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observing migrations in the first two weeks that other studies missed due to their late
baseline images [24,26]. Similar to other studies, we saw small amounts of implant
valgus rotation, anterior tilt, lateral-medial translation and posterior-anterior translation
which is consistent with reports in the literature from other cementless stems.
In both implant groups there were instances where the implant greatly exceeded the mean
magnitude of migration (Figure 21). One of the collared femoral stems was not inserted
completely during the procedure resulting in a lack of collar-calcar contact. This patient
experienced constant implant subsidence to six weeks that no other patients receiving
collared implants experienced. They experienced the same valgus rotation as the other
collared implants but experienced more external rotation during the six weeks that the
collar was not resting on the calcar. This incomplete insertion resulted in it acting more
like a collarless stem while subsiding into its ultimate position. Two of the patients that
received collarless implants experienced large amounts of subsidence and valgus rotation
as well as varying amounts of internal-external rotation in the first two weeks that was
not seen in the other patients receiving collarless implants. This could lend support to the
idea that without a collar, implants that are not properly inserted into the femur will
migrate large amounts until mechanical stability is reached. The large amount of implant
subsidence in these three cases show the magnitude of implant migration when a stem
does not achieve optimal primary fixation intra-operatively. This can potentially lead to
leg length discrepancies noticeable to patients.
The primary limitation of this study is the assessment of a single device. A secondary
limitation of this study is the lack of evaluation ensuring that all collared implants had the
collar resting on the calcar intraoperatively. A third limitation is the time-period between
the operation and our baseline RSA imaging. Patients did bear weight before the baseline
exam, <24 hours after the procedure, and as a result we may not have captured all of the
implant migration. This RSA study is ideal for predicting long term implant stability as
there is a detailed understanding of the early variations between designs. When patients
are called back for five-, ten- and even twenty-year post-operative imaging, we will be
able to determine the impact that these early migrations had on their long-term stability.
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In conclusion, both the collared and collarless femoral stems illustrate good early fixation
in the first three months with the majority of the stem migration occurring in the first two
weeks post operatively. When comparing between the implants following a DA THA
procedure it was observed that collared stems experience significantly less subsidence
than their collarless counterpart in the first two weeks. It was also observed that, although
small, there was significantly less anterior-tilt for collared stems compared to collarless
stems as well. No significant differences were observed between groups for any
migrations that occurred between two weeks and three months.
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Chapter 3

3

Understanding the Impact Femoral Implant Design has
on Patient Activity and Function

3.1 Introduction
3.1.1

Total Hip Arthroplasty

Osteoarthritis (OA) is a degenerative disease that impacts over 37% of the Canadian
population and affects the load bearing joints of the body [1]. Individuals who suffer
from end-stage hip OA may elect to undergo total hip arthroplasty (THA). THA is a
procedure known to both reduce pain and improve patient function [2]. This surgical
procedure is among the most common elective surgeries performed in Canada, with over
50,000 annually conducted and this number is expected to continue rising [3]. There is
increasing pressure for THA procedures to provide improved rapid recovery care,
pushing for better implant stability earlier on [4].
There are many different surgical approaches that can be used to perform a THA. The
three main approaches are the direct anterior (DA), direct lateral (DL) and direct posterior
(DP) with each one having its own advantages and disadvantages. The muscle sparing
nature of the DA approach leads to a reduction in recovery time as well as less pain postoperatively that the others do not [2]. Studies have shown that early activity postoperatively can result in a positive impact in the recovery process after the arthroplasty
procedure [5–7].
An adequate understanding of patient functionality is an integral component of providing
the best possible care and possibly support enhanced recovery pathways. It is important
to interpret the impact that varying implant designs have on recovery. Orthopaedic
implant manufacturers have developed femoral stems to provide stability of the femoral
component [8]. Femoral stem micromotion may result in a failure of the implant to
properly in-grow [9]. This may ultimately lead to pain that can in turn impact a patient’s
activity and function. Manufacturers have modified their implants to improve implant
stability such as the addition of a medially placed collar on the femoral stem. It is
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important to clinically test the impact that these new designs have on patient recovery. If
this design improves patient early recovery then it can be beneficial to the rapid recovery
care pathways sought after by current health care providers.
Physical assessments and patient reported outcome measures (PROMs) are standards of
practice used by clinicians to assess an individual’s function pre- and post-operatively. A
limiting factor of PROMs is their vulnerability to bias and ceiling effects [10]. Although
unintentional, when patients are asked to report unbiased measures, there is a risk that
unrealistic personal expectations may impact the outcomes. Standard pre- and postoperative assessments include clinicians asking patients to briefly walk up and down a
hall. This test provides the necessary information to determine what specific functional
impairments they are experiencing. It is difficult to assess all aspects of the patient’s
stride during this test. Instrumenting a functional test to assess this would provide an
objective unbiased metric necessary to analyze a patient’s progress. The timed-up-and-go
(TUG) test is a frequently used measure of an individual’s mobility. Originating as a risk
assessment for falls, the TUG test has been validated for clinical use to assess patients in
rehabilitation programs [11]. Historically, clinicians have been focused on the total time
to complete the test. Instrumenting this test using wearable inertial sensors proximal and
distal to each knee would provide unbiased objective metrics to quantify individual
patient functionality. This test can be repeated throughout recovery to assess an
individual’s recovery process. Another benefit of instrumenting this test is the ability to
gain insight into the different functional components the patient is required to
accomplish. The TUG test has shown good test-retest reliability [12]. Another method to
objectively assess patient activity throughout recovery is using off-the-shelf activity
trackers. These fitness trackers are validated to accurately monitor an individual’s steps
[13]. Measuring the change in a patient’s average steps per day during the early recovery
period can also give more insight into the daily recovery a patient is experiencing.
The purpose of this study was to measure the impact collared and collarless femoral
stems have on activity and function of patients during the early recover period following
THA via the DA surgical approach. We hypothesize that patients receiving collared
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implants will have more activity and function earlier in recovery compared to those
patients receiving the collarless implant.

3.2 Methods
Research ethics board approval was obtained prior to patients being enrolled in this study.
Recruitment occurred between January 2018 and February 2019. Patients undergoing a
primary unilateral THA procedure for hip OA were eligible to participate in this
prospective randomized clinical trial.

3.2.1

Inclusion and Exclusion Criteria

Patients included in this study were diagnosed with unilateral hip OA and set to undergo
a primary THA procedure. The following are the exclusion criteria used to determine
patient eligibility: A BMI greater than 40, symptomatic contralateral OA, bilateral or
revision THA procedures, cognitive or neuromuscular disorders, the inability to
understand English and if the patient lived more than 100km from our research centre in
London, Ontario.

3.2.2

Surgical Intervention

Patients were referred to the University Hospital, London Health Sciences Centre. Those
who were undergoing the DA surgical approach were randomly selected pre-operatively
to either receive a collared or a collarless Depuy Corail femoral stem (Figure 22). A
block randomization with concealed envelopes was used to assign participants to either
receive a collared or a collarless implant.

3.2.3

Activity Follow-Up

Each patient was given a FitbitTM (San Francisco, CA) activity tracker at their preadmission appointment prior to surgery to allow the average steps per day taken
throughout recovery to be recorded. Patients were asked to wear the activity tracker every
day for a minimum of a full week prior to each visit to the hospital (day of surgery, two-,
four-, six-weeks, and three months). The average steps taken per day over seven days
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prior to each follow-up visit was used to calculate an average number of daily steps taken
for each visit.

3.2.4

TUG Follow-Up

Patients completed an instrumented TUG test at each visit (pre-operatively, two-, four-,
six-weeks, and three months). This test required patients to wear inertial sensors, one
distal and one proximal to each knee to measure flexion, velocity and acceleration of
each lower limb segment [14]. Patients were asked to start in a seated position, stand up
and walk to a marker three metres away, turn around at the marker, walk back to the chair
and sit down. Chairs of the same height were used for all tests and patients were asked to
complete the test three times and the average was recorded.
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Assessed for eligibility (n=190)

Ineligible (n=77)
Lives more than 100km from London, ON (n=49)
BMI > 40 (n=5)
Contralateral symptomatic OA (n=9)
THA not due to OA (n=4)
Planned to undergo DL approach (n=5)
Cognitive issues (n=1)
Knee OA (n=1)
Recruited into a different study (n=1)
Bad bone quality (n=1)

Approached in Pre-Admission
Clinic (n=113)
Ineligible (n=65)
Did not meet (n=23)
Did not successfully recruit (n=42)

Randomized (n=48)

Collared (n=24)

Allocation

Received allocated intervention (n=19)
Did not receive allocated intervention (n=5)

Received allocated intervention (n=23)
Did not receive allocated intervention (n=1)

Different stem (n=2)
Withdrew prior to surgery (n=3)

Fitbit

TUG

Data at time-point (n=12)

Data at time-point (n=14)

Collarless (n=24)

Withdrew prior to surgery (n=1)

3 Month
Follow-Up

Fitbit

TUG

Data at time-point (n=13)

Data at time-point (n=15)

Figure 22: Participant flow through the study

3.2.5

Patient Reported Outcome Measure Follow-Up

Demographics were collected pre-operatively for both groups (Error! Reference source n
ot found.). The Short Form 12 (SF-12), University of California, Los Angeles (UCLA)
activity score, the Western Ontario and McMaster Universities Arthritis Index
(WOMAC), and the Harris Hip Score (HHS) were collected for each patient preoperatively and at three months post-operatively. The UCLA activity score was collected
at an additional three visits at two-, four- and six-weeks post-operatively.
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3.2.6

Statistical Analysis

Demographics, patient reported outcome measures (PROMs), TUG metrics and FitbitTM
metrics were reported with descriptive statistics including means, standard deviations and
ranges. Data was tested to be normal or not to determine which statistical tests were
appropriate. Demographics between groups were compared using unpaired t-tests, while
the ratios of male:female and right:left hip was compared using a Fisher’s exact test. To
compare the average steps per day as well as TUG metrics throughout recovery, a 2-way
ANOVA was used. The outcome scores will be compared between groups using a MannWhitney test. All statistical tests were conducted using GraphPad Prism.

3.3 Results
3.3.1

Demographics

There were no differences in patient demographics (Table 4), SF-12, WOMAC, HHS or
UCLA outcome measures (Table 5) between the implant groups.
Table 4: Patient demographics for the two implant groups, presented as mean ±
standard deviations (where applicable)
Characteristic
Age at surgery (years)
Patient sex
Surgical side
Height (m)
Weight (kg)
BMI (kg/m2)

Collared

Collarless

p value

64.6 ± 8.7
12 Male, 7 Female
12 Left, 7 Right
1.75 ± 0.08
88.69 ± 18.44
28.80 ± 5.1

65.0 ± 8.1
12 Male, 11 Female
9 Left, 14 Right
1.73 ± 0.11
91.31 ± 20.83
30.35 ± 4.89

0.872
0.542
0.214
0.393
0.672
0.321
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Table 5: Clinical outcome scores, presented as mean ± standard deviation, minimum
and maximum values
Outcome Measure
SF-12 MCS
Pre-Operation
3 Months

Collared

Collarless

55.15 ± 9.17
(36.52 to 66.40)
58.17 ± 3.35
(52.96 to 62.97)

57.28 ± 5.96
(45.84 to 65.73)
58.16 ± 4.35
(51.16 to 61.97)

36.64 ± 10.88
(23.79 to 57.29)
49.80 ± 5.29
(39.27 to 55.50)

30.65 ± 8.81
(20.44 to 46.86)
43.08 ± 10.64
(28.49 to 55.26)

52.67 ± 13.24
(28.09 to 86.16)
88.64 ± 6.28
(80.78 to 100.0)

47.31 ± 18.95
(15.94 to 77.27)
77.79 ± 18.00
(51.11 to 100.0)

62.44 ± 7.81
(45.00 to 75.00)
98.33 ± 2.88
(93.00 to 100.0)

55.88 ± 10.33
(39.00 to 73.00)
96.80 ± 4.43
(91.00 to 100.0)

5.53 ± 1.65
(3 to 8)
3.80 ± 1.57
(2 to 8)
4.93 ± 1.54
(3 to 8)
5.67 ± 1.54
(3 to 8)
6.86 ± 1.41
(4 to 9)

5.22 ± 1.78
(2 to 6)
3.32 ± 0.95
(2 to 6)
4.40 ± 1.19
(3 to 6)
4.85 ± 1.60
(3 to 8)
6.47 ± 1.51
(4 to 8)

0.16 ± 0.50
(0 to 2)

0.39 ± 0.66
(0 to 2)

p value
0.431
0.370

SF-12 PCS
Pre-Operation
3 Months

0.091
0.142

WOMAC Total
Pre-Operation
3 Months

0.356
0.077

HHS Total
Pre-Operation
3 Months

0.188
0.220

UCLA
Pre-Operation
2 Weeks
4 Weeks
6 Weeks
3 Months

0.566
0.455
0.267
0.139
0.478

Comorbidity Index
Pre-Operation

3.3.2

0.167

Activity – Pre-Operation to Three months

The average steps taken per day for patients that received a collared and a collarless stem
is shown in Figure 23. The collared group took significantly more steps than the
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collarless group at six weeks (mean difference = 2468 steps, p = 0.032) and three months
(mean difference = 3010 steps, p = 0.036). The collared group was also taking
significantly more steps at three months than they were pre-operatively (mean difference
= 3311 steps, p = 0.001). The collarless group was taking significantly less steps at six
weeks than they were pre-operatively (mean difference = 1830 steps, p = 0.021). There
was no significant difference between groups pre-operatively (mean difference = 334
steps, p > 0.999), at two weeks (mean difference = 557 steps, p > 0.999) or at four weeks
(mean difference = 1035 steps, p > 0.999).

Activity
15000

Collared

Steps/Day

12000

Collarless

*

9000

*

6000
3000
0
Pre-Op

2

4

6

12

Weeks Following Surgery

Figure 23: Line graph showing the average steps taken per day for patients that
received a collared and a collarless femoral stem over three months (12 weeks)

3.3.3

Function – Pre-Operation to Three months

The total time taken to complete the TUG test for patients that received a collared and a
collarless stem is shown in Figure 24. The collared group took significantly less time to
complete the TUG test at three months than they did pre-operatively (mean difference =
3.26 s, p = 0.042). The collarless group also took significantly less time to complete the
TUG test at three months than they did pre-operatively (mean difference = 3.66 s, p =
0.002). There were no significant differences between groups pre-operatively (mean
difference = 0.35 s, p > 0.999), at two weeks (mean difference = 0.55 s, p > 0.999), at
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four weeks (mean difference = 0.04 s, p > 0.999), at six weeks (mean difference = 0.44 s,
p > 0.999) or at three months (mean difference = 0.05 s, p > 0.999).
Pre-operative measurements between groups showed no significant differences for their
operative limb flexion angles (p = 0.970), velocities (p = 0.864) or accelerations (p =
0.471) as well as for their non-operative limb flexion angles (p = 0.481), velocities (p =
0.381) or acceleration (p = 0.888). At three months there were also no significant
differences measured between groups for their operated limb measurements of flexion
angles (p = 0.611), velocities (p = 0.438) or accelerations (p = 0.491) as well as for their
non-operated limb measurements of flexion angles (p = 0.552), velocities (p = 0.619) or
acceleration (p = 0.623).

Function
30

Collared

Collarless

Time (s)

25
20
15
10
5
0
Pre-Op

2

4

6

12

Weeks Following Surgery

Figure 24: Line graph showing the average total time taken to complete the TUG
test for patients that received a collared and a collarless femoral stem over three
months (12 weeks)

3.4 Discussion
To our knowledge, this prospective study is the first to assess the impact having a
collared or collarless stem design has on patient activity and function during the early
recovery period after a primary THA. Our study describes the recovery process for
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patients receiving both collared and collarless cementless femoral stems. By three months
post-operation, patients experienced improved activity and function compared to their
pre-operative baselines in both groups. We reported no significant differences between
groups prior to surgery. We also saw no differences between groups at any time-points
for PROMs. According to multiple studies, questionnaires suffer from ceiling and bias
effects limiting the amount we can tell from these patients [10,15,16]. This study partially
supports our hypothesis expressing the increased level of activity in patients receiving
collared implants compared to patients receiving collarless implants, but the same level
of function.
Current literature has indicated that there is a minimal adjustment to a patient’s lifestyle
after their procedure to incorporate more activity. de Groot et al [17] reported on 80
patients undergoing a total joint arthroplasty and measured only a 0.7% increase in
physical activity at six months post-operation compared to their pre-operative levels. A
recent literature review concluded that activity levels can be accurately measured using
pedometers [18]. Fujita et al [19] reported that patients set to undergo a primary THA
procedure take an average of 4632 ± 2246 steps per day pre-operatively and by six
months they are taking 5657 ± 2106 steps per day. They reported a significant increase in
average steps taken after six months of recovery. A limitation of their study is the lack of
information obtained within that first six-month time-frame. Our study measured a
significant increase in the number of steps taken per day as early as three months
compared to pre-operative step counts for patients receiving collared implants. The
average steps taken per day for patients in our study that received the collarless stem
agrees with the literature as they were still not taking significantly more steps three
months post-operation than they were pre-operation. However, we also observed that
patients receiving collared implants were already taking the same number of steps at six
weeks (7202 ± 2800) and more steps at three months (9542 ± 3411) than the healthy
controls (7228 ± 3132) reported by Fujita et al [19]. Studies have shown that there is still
a risk of thigh pain after successful THAs [20]. According to Demey et al [8] the forces
required to cause a collared implant to subside are much greater than those needed to
cause a collarless implant to subside. This pain can be caused by a variety of factors, one
of which is bone-prosthesis micromotion that may lead to a reduction in activity early in
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recovery as a result of this pain. In the previous chapter of this thesis, we reported that
micromotion leading to subsidence is more apparent in collarless implants. This may
result in leg length discrepancy and may be an explanation as to why we observed
patients receiving collared implants taking significantly more steps per day at six weeks
and three months compared to patients receiving collarless implants when there was no
significant difference seen between these groups pre-operatively.
Unlike with activity, there were no functional significant differences observed between
patients receiving collared and collarless implants (p=0.861) throughout recovery. We
assessed function by having patients complete a TUG test while we measured the total
time taken to complete the test along with various metrics assessing flexion, acceleration
and velocity of each limb. Yuksel et al [12] validated the use of this test and found it to
be sensitive in detecting changes in patients recovering from joint replacement surgeries.
They determined the smallest detectable change for this test to be 2.27 seconds [12]. As
walking is related to an active and independent lifestyle, this assessment after total joint
arthroplasties provides crucial information about the healing process [21,22]. Studies
have reported the TUG test to be a simple, reliable and valid test used to assess various
populations as well as leg strength [11,23,24]. Poitras et al [25] conducted a study that
used the TUG test to assess the functional recovery of total hip arthroplasty patients.
They found patients to take 10.8 ± 4.6 s pre-operatively, 12.4 ± 4.3 s at two weeks and
9.4 ± 3.0 s at six weeks. The difference in time to complete the test between the three
time-points in their study was less than 2.27 s, implying that there were no clinically
relevant changes between follow-ups. Our study expressed the same trend, although
showing a clinically relevant increase in time to complete the TUG test at two weeks and
an eventual decrease in time approaching six weeks. Both groups in our study
experienced improvements in TUG test time exceeding 3 seconds from pre-operation to
three months, representing a clinically meaningful improvement in function. It has been
reported that patients who take longer than 14 seconds to complete the TUG test are at a
high risk of falls [26]. Patients in both groups in our study are classified under the high
risk of falls category at two weeks, and already at four weeks they are in the low risk
category. This risk continued to decrease approaching three months. We observed no
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difference in flexion, acceleration or velocity of each limb at any time point which
suggests that both groups are walking functionally similar throughout their recovery.
The primary limitation of this study is the small number of patients in each group.
Another limitation is our assessment of only one surgical approach. Observing these
stems in patients undergoing different surgical approaches will shed more light on the
impact this has on patient activity and function throughout recovery. Lastly, a limitation
of this study is the use of wearable activity trackers while patients are using gait aids. We
did however find that there was no significant difference between groups at any time
point for how many were using gait aids.
In conclusion, the collared femoral stem allows patients to become more active earlier in
their recovery process compared to the collarless femoral stem. The average steps taken
per day for patients receiving collared implants was 2468 more than patients receiving
collarless implants at six weeks and 3010 more at three months post-operatively.
However, there was no measurable difference in the time to complete the TUG test
between groups at the three-month time-point, although both groups had clinically
meaningful improvements in function at three months compared to pre-operatively.
Surgeons can take this information into account when planning DA THA procedures as it
allows patients to be more active earlier. We can conclude that the collared femoral stem
assists in providing patients with a rapid recovery.
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Chapter 4

4

Conclusion

4.1 Overview of Objectives
Our study assessed the impact implant design has on femoral stem migration and patient
recovery. The increasing demand for rapid recovery care puts increasing pressure on
outpatient procedures such as the direct anterior (DA) approach to be used. In order to
provide this care, orthopaedic industry partners need to adapt to ensure patients are
receiving the best possible treatment to benefit their recovery. The specific objectives of
this study were to better understand the impact a collar on the femoral stem has on
implant migration, patient activity, and patient function throughout the early recovery
period.

4.2 Summary of Results
In chapter two of this thesis, the early implant migration patterns for collared and
collarless femoral stems were assessed. Translations and rotations were measured for
each implant at two-, four-, six-weeks and three months post-operatively using a baseline
radiostereometric analysis (RSA) exam within 24 hours after their procedure. It was
concluded that collared femoral stems have more stability earlier in recovery compared to
collarless femoral stems as seen by the significantly less subsidence and anterior-tilt
experienced within the first two weeks. There were no significant differences in stem
migrations between groups from two weeks onwards. The early baseline RSA exam in
this study is something to be considered when designing RSA studies assessing implant
migration. Studies often have two- or six-week baseline exams missing the early
migrations. Both stems are currently used for THA procedures. The results of this study
will better inform surgeons on which implant should be used to ensure a more stable
fixation earlier in recovery.
In chapter three of this thesis, the impact femoral stem design has on patient activity and
function was analyzed. This study demonstrated that patients receiving the collared
femoral stem were more active earlier on in recovery. This study found patients in the
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collared group taking significantly more steps per day on average compared to those in
the collarless group as early as six weeks post-operatively. Although this study found a
difference in patient activity, patients had similar function throughout their early recovery
between groups. There was a clinically meaningful improvement in function at three
months post-operation in comparison to pre-operation within patients that received
collared and collarless implants. The results of this study will provide surgeons with a
better understanding of which implant provides the best early recovery to improve the
rapid recovery care process.

4.3 Future Directions
For this master’s thesis, implant migration, patient activity and patient function for
individuals undergoing the DA approach was assessed. These patients either received a
collared or a collarless implant and were evaluated over the first three months postoperatively. While this thesis provides important insight into the variation in recovery
patterns between the two implant groups, it does not touch on the impact these different
stem designs have on patients receiving the direct lateral or direct posterior surgical
approaches. Future research in this area should include an analysis on the impact stem
design has on implant migration, patient activity and patient function after undergoing
different surgical approaches. Future work should also be conducted assessing these
patients longer into their recovery. This will provide information on the impact these
stem designs and surgical approaches have on long term recovery.

4.4 Conclusions
This thesis set out to establish the relationship between implant design and implant
migration, and implant design and recovery progression for patients undergoing the DA
surgical approach for a total hip arthroplasty (THA). This thesis provides strong evidence
towards the connection between using a collared stem and reducing implant migration.
This thesis also provides evidence for patients improving early recovery after THA
procedures when receiving collared femoral stems. By incorporating these findings into
pre-surgical planning, patient recovery timelines may be reduced by utilizing the collared
femoral stem.

70

Appendices
Appendix A: Ethics Approval

LAWSON FINAL APPROVAL NOTICE
LAWSON APPROVAL NUMBER: R-17-461
PROJECT TITLE: The Collared Femoral Component: Supporting the Transition to
Enhanced Recovery Pathways?
PRINCIPAL INVESTIGATOR:

Dr. Brent Lanting

LAWSON APPROVAL DATE:

Thursday, 7 December 2017

Health Sciences REB#:

109401

ReDA ID:

4053

Please be advised the above project was reviewed by Lawson Administration and the
project:
Was Approved

Please provide your Lawson Approval Number (R#) to the appropriate
contact(s) in supporting departments (eg. Lab Services, Diagnostic
Imaging, etc.) to inform them that your study is starting. The Lawson
Approval Number must be provided each time services are requested.
Dr. David Hill
V.P. Research
Lawson Health Research Institute
All future correspondence concerning this study should include the Lawson Approval Number
and should be directed to Sherry Paiva, Research Approval Officer, Lawson Health Research
Institute, 750 Baseline Road, East, Suite 300.

cc: Administration

71

Appendix B: Letter of Information and Consent

Comparing direct anterior and lateral surgical approaches for collared and
collarless implants and correlating joint motion to hip implant performance.
Principle Investigator
Dr. Brent Lanting
Co-Investigators
Dr. Edward Vasarhelyi
Dr. Jacquelyn Marsh
Dr. Matthew Teeter

519-663-3335

519-663-3413

Study Coordinators
Maxwell Perelgut
Bryn Zomar
Harley Williams
Jordan Broberg

519-685-8500 x32245
519-685-8500 x34269
519-685-8500 x32245
519-685-8500 x32245

You are being invited to voluntarily participate in a research study designed for patients undergoing
total hip replacement (THR) surgery at London Health Sciences Centre. This letter of information
describes the research study and your role as a participant. Please read this letter of information
carefully. Do not hesitate to ask anything about the information provided. Your surgeon or the study
coordinator will describe the study and answer your questions. You may take as much time as you
need to decide whether to participate and can discuss participation with your friends, family, family
doctor, etc.
PURPOSE
There are two main designs of implants used in THR, collared and collarless (see image below).The
collared implant has a lip at the top edge has been shown to provide improved resistance to twisting
(stability), but it’s unknown if this increase in stability improves early function for patients. Greater
stability immediately after surgery would provide surgeons with greater confidence that their
patients can embark on rapid recovery pathways (earlier discharge from hospital, quicker
rehabilitation, quicker return to activities), but not all surgeons are supportive of collared implants
due to a lack of literature demonstrating the benefits.

A. Collarless hip implant
B. Collared hip implant
23 Jan 2018
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_______________

Participant’s Initials
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The purpose of this study is to compare movement of the hip implant between the collared and
collarless implant designs up to 2 years after surgery. This study will also compare implant
movement between two common surgical approaches used by the surgeons at University Hospital,
the direct anterior (incision from the front) and the direct lateral (incision from the side).
PROCEDURE
This is a randomized study with 50 participants in each group for a total of 100 participants. Eligible
patients receiving THR surgery will be enrolled if they meet the inclusion criteria, and will then be
randomized to undergo a THR with either a collared or collarless implant. Both types of implant are
used by the surgeons’ in their normal standard practice. You will be randomly assigned, like the flip
of a coin, to one of the two groups. You will not be told which group you have been randomized to
until you reach the final study visit. The surgical approach used during your surgery is determined
based on your surgeon’s preference and is not affected by your participation in this study.
During your surgery you will have tantalum beads inserted into the top of your thigh bone and
around the socket of your pelvis (at your hip joint). These beads are the size of the head of a pin and
will have no impact on how your hip will function after the surgery. The tantalum beads will be used
as markers to assess for any microscopic movement of the implant and will remain in place
indefinitely. To measure this movement, we will ask you to have a special kind of x-ray called
radiostereometric analysis (RSA) taken after surgery on the day you are discharged from the hospital
and at every follow-up visit. A member of the study team will escort you to Robarts Research
Institute (attached to University Hospital) where the x-rays will be taken, and a wheelchair will be
provided for you if needed. The x-ray will take less than 15 minutes to complete. These x-rays will
be taken in addition to the standard x-rays taken as part of the standard of care at the hospital.
You will be asked to complete questionnaires that will assess your functional ability, quality of life
and costs at specific visits after surgery. These questionnaires will take approximately 20 minutes to
complete.
You will also be asked to perform the Timed Up and Go (TUG) at each visit. Any gait aids (such as
a cane, crutches or walker) that are normally used will be permitted during the TUG. The TUG
involves getting up from a chair, walking 3 metres to a point marked on the floor, turning around and
returning to sitting in the chair. During the TUG we will have you wear sensors that will measure
speed, step length, stride length, etc. As part of this study you will also be given a FitBit (a type of
pedometer, worn in a bracelet, that can track your activity) to wear for 7 days prior to your surgery
and each visit to the clinic. You will be asked to set up an account with FitBit at your first visit
(research staff will assist you with this) and at each follow-up visit you will be asked to log into your
account to download the data.
For this study, in addition to the standard visits to the hospital after surgery (at 2 weeks, 6 weeks, 3
months, 1 year and 2 years), we will ask you to also come in at 4 weeks and 6 months specifically
for the research study. Standard x-rays will still be taken at 6 weeks, 1 year and 2 years as part of
your normal clinic appointments. Questionnaires and study specific testing will occur at each visit
outlined in the flow chart below.
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PreOp
Questionnaires
TUG
FitBit x7 days

Discharge
RSA

2,4 weeks
RSA
Questionnaires
TUG
FitBit x7 days

6 weeks;
3,6 months;
1 year
RSA
Questionnaires
TUG
FitBit x7 days
Cost Forms

2 Years
RSA
Questionnaires
TUG
FitBit x7 days

INCLUSION AND EXCLUSION CRITERIA
You will be eligible to participate in this study if you:
1. Have osteoarthritis in one of your hips;
2. Will have a total hip replacement.
You will not be eligible to participate in this study if you:
1. Have osteoarthritis in your other hip;
2. Will have a revision hip replacement;
3. Will have both hips replaced in the same surgery;
4. Have a neuromuscular disorder that would prevent you from performing the TUG;
5. Have a body mass index greater than 40;
6. Live more than 100 km from London, Ontario;
7. Are unable to understand English, as questionnaires are only provided in English.
RISKS
Both implant designs and surgical approaches used in the study are part of the surgeons’ standard
practice. Standard anesthetic and surgical risks that apply in standard practice will apply to you. You
can opt out of any questionnaires that make you uncomfortable. You could fall or injure yourself
while performing the walk tests; however, the risks are no greater than those encountered with
typical postoperative rehab protocols.
There is always a slight chance of cancer from excessive exposure to radiation. Special care is taken
during x-ray examinations to use the lowest radiation dose possible while producing the best images
for evaluation.
The scientific unit of measurement for radiation dose is the millisevert (mSv). People are exposed to
radiation from natural sources all the time. The average person receives an effective dose of about 35 mSV per year from naturally occurring radioactive materials and cosmic radiation from outer
space. The 8 RSA examinations in this study will expose you to 1.2 mSv of ionizing radiation, or
40% of the yearly background radiation we are all exposed to yearly.
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The tantalum bead insertion is an additional procedure that is not used in routine surgery. The beads
are secured in the bone and there is little to no significant risk related to their insertion.
BENEFITS
There are no known benefits to you for taking part in this study; however, possible benefits may
include greater stability in the collared implant group. The findings from this study will contribute to
our improvement in the treatment of future patients undergoing THR. This study will help identify if
one type of implant provides greater stability and reduces the risk of future revision surgery.
NEW INFORMATION
During the study, you will be informed of any significant new finding (either good or bad), such as
changes in the risks or benefits resulting from participation in the study or new alternatives to
participation that might change your decision to continue participating in this study. If new
information is provided to you, written consent to continue participating in this study will be
requested.

RESEARCH RELATED INJURY
If you become ill or injured as a direct result of participating in this trial, necessary medical
treatment will be available at no additional cost to you. Your signature on the consent only indicates
that you have read to your satisfaction the information regarding your participation in the study and
agree to participate in the trial. In no way does this waive your legal rights nor release the Principal
Investigator, the research team, or involved institutions from their legal and professional
responsibilities.
CONFIDENTIALITY
Any personal health information collected or other information related to you will be de-identified
with a unique number to ensure that persons outside of the study will not be able to identify you. In
any publication, presentation or report, your name will not be used and any information that
discloses your identity will not be released or published unless required by law. Despite these
protections being in place, there is always a risk of unintentional release of information. The study
personnel will protect your records and keep all the information in your study file confidential to the
greatest extent possible. The chance that this information will be accidentally released is small.
When you create your FitBit account, you will be asked to provide an email address and some
personal information (such as birthdate, height, weight, etc.), however, only your email address is
required to set up your account. Research staff will not have access to your account. There is a
remote chance that your account could be “hacked” by someone who is not supposed to have your
information, but this risk is small.
RSA image data will be processed at the Robarts Research Institute, a secure research facility. This
data will be stored on a password-protected computer, and will be made anonymous by coding it
with a numeric identifier.
23 Jan 2018
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Study data will be kept for 15 years. Representatives of the University of Western Ontario Health
Sciences Research Ethics Board may require access to your study-related records or follow-up with
you to monitor the conduct of this research. Representatives of Lawson Quality Assurance (QA)
Education Program may look at study data for QA purposes.
VOLUNTARY PARTICIPATION
Participation in this study is completely voluntary. You may refuse to answer any questions you do
not want to answer and remain in the study. You are free to withdraw at any time without affecting
the quality of the care you receive at this institution, and by signing this form you do not waive your
legal rights. When you withdraw your permission, no new health information will be gathered after
that date. Information that has already been gathered may still be used. If you would like to
withdraw from this study, you will need to provide written or verbal confirmation to the study
coordinator: Maxwell Perelgut at 519-685-8500 x32245.
ALTERNATIVES TO STUDY PARTICIPATION
If you choose not to participate, you will continue to be followed by your surgeon as per standard of
care for all orthopaedic joint replacement patients.
COST/COMPENSATION
Parking passes will be provided for visits that are outside standard of care (4-weeks and 6-months
after surgery). You will also be allowed to keep the FitBit at the end of the study.
CONFLICT OF INTEREST
Drs. Brent Lanting and Edward Vasarhelyi are both paid consultants for DePuy, which is the
company that manufactures the Corail implant and provides funding for this research study. If this
study were to find very positive outcomes of this implant, it is very unlikely that these consultants
will receive any benefit. DePuy is not involved in study conduct, but will receive a report of study
results once the study is complete.
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CONTACT FOR QUESTIONS
If you have any questions about your rights as a research participant or the conduct of this study, you
may contact the Office of Human Research Ethics at 519-661-3036 or ethics@uwo.ca.
For more information concerning this study and research-related risks or injuries, you may contact
the Principal Investigator, Dr. Brent Lanting, at 519-663-3335, or the study coordinator Maxwell
Perelgut, at 519-685-8500 x32245.
You will be provided with a copy of this consent document once it has been signed.
Sincerely,
Dr. Brent Lanting, MD, FRCSC
Dr. Edward Vasarhelyi, MD, FRCSC
Dr. Jacquelyn Marsh, PhD
Dr. Matthew Teeter, PhD
Bryn Zomar, MSc, PhD(c)
Maxwell Perelgut, Master’s Student
Harley Williams, Master’s Student
Jordan Broberg, Master’s Student
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Letter of Consent
Comparing direct anterior and lateral surgical approaches for collared and
collarless implants and correlating joint motion to hip implant performance.
I have read the Letter of Information, have had the nature of the study explained to me and I agree to
participate. All questions have been answered to my satisfaction. I will receive a copy of the Letter
of Information and this signed consent form.

Print participant’s full name

Date

Participant’s signature

Name of person obtaining consent

Date

Signature of person obtaining consent
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Appendix C: Screening and Consent Document

Collared/Collarless Screening and Consent Document
Patient Name: ____________________

Patient PIN: ___________________________

Date Screened: ___________________

Estimated Surgery Date: _________________

Mailed: □ Yes

Preadmission Date: _____________________

Surgeon:

□ No _______________
□ Lanting □ Vasarhelyi

Inclusion Criteria:

1. Osteoarthritis of the hip?
2. Booked for primary unilateral total hip arthroplasty?
2. Access to a computer or a smartphone?

Exclusion Criteria: 1. Symptomatic osteoarthritis in the contralateral hip?
2. Bilateral total hip arthroplasty?
3. Revision arthroplasty?
4. Cognitive defects/neuromuscular disorders?
5. Inability to understand English?
6. Live more than 100km from London, Ontario
7. BMI greater than 40?

□ Yes □ No
□ Yes □ No
□ Yes □ No
□ Yes
□ Yes
□ Yes
□ Yes
□ Yes
□ Yes
□ Yes

□ No
□ No
□ No
□ No
□ No
□ No
□ No

□ Eligible
□ Ineligible
□ Meets inclusion criteria, but declined
□ Other: __________________________________________________________

Status:

Consent Discussion:
Was the study explained to the patient in detail?
Did the patient have any questions?
Were all questions answered to the patient’s satisfaction?
Was the patient given time to read the consent form?
Did the patient need more time to think about the study?
Was the consent form signed?
Was a copy of the consent given to the patient?

□ Yes
□ Yes
□ Yes
□ Yes
□ Yes
□ Yes
□ Yes

□ No
□ No
□ No
□ No
□ No
□ No
□ No
1

16-Jan-2019
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Questions asked by patient:
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
Surgeon Reviewed Eligibility (sign and date): _________________________________________
Date Randomized: ______________________________________________________________
Notes:
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
Signature: ________________________________

Date: _________________________

2
16-Jan-2019
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Appendix D: Demographics Questionnaire

Collared vs Collarless RCT

Study ID: ____________
Date: _______________
Demographics

1. Age: ____________________
2. Operative Hip:

Left

Right
Yes

3. Do you have symptoms in your other hip?
4. Dominant Side:

Left

Right

5. Gender:

Male

Female

6. Height: ___________

No

Weight: ___________

7. Do you currently smoke cigarettes?
I have never smoked
No, I quit more than 12 months ago
No, I quit in the last 12 months
Yes:
How often do you smoke?

Every day
Some days

8. How much schooling have you completed?
Less than high school
Some college
Postgraduate school or degree

Graduated from high school
Graduated from college

9. Which statements describe your current employment situation?
Currently working
□ Full Time
□ Part Time
Disability/WSIB
Unemployed
10.

Homemaker
Student
Retired (not due to ill health)
Retired (due to ill health)
Other ________________________

Check this box if you are off work for reasons unrelated to your hip problem.
Please describe the reason: ______________________________________

11. What is your current marital situation?
Married
Living with significant other
Divorced/Separated
Widowed
Single (never married)
Version: 12-Jan-2018
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Collared vs Collarless RCT

Study ID: ____________
Date: _______________

12. Please indicate your living status (pre-hip replacement).
Living alone
Living with spouse/partner
Living with family (includes extended)
Living with non-family, unpaid (includes friends)
Living with paid attendant
Living in residential care facility
Living in hospital/long-term care/nursing home
Other ______________________________
13. Are there stairs where you live that you are required to use?
No

Yes

14. Have you had a previous joint replacement?
No

Version: 12-Jan-2018

Yes:

Other Hip
Right Knee
Left Knee
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Appendix E: Short Form 12 (SF-12)

Collared vs Collarless RCT

Study ID: ___________
Date: _______________
SF-12

INSTRUCTIONS: This survey asks for your views about your health. This information will help keep track of how
you feel and how well you are able to do your usual activities. Answer every question by marking the answer as
indicated. If you are unsure about how to answer a question, please give the best answer you can.
1. In general, would you say your health is:

Excellent
(1)

Very Good
(2)

Good
(3)

Fair
(4)

Poor
(5)

The following items are about activities you might do during a typical day. Does your health now limit you in these
activities? If so, how much:

2. Moderate activities, such as moving a table, pushing a vacuum
cleaner, bowling, or playing golf.
3. Climbing several flights of stairs.

Yes, Limited
A Lot
1

Yes, Limited
A Little
2

No, Not
Limited At All
3

1

2

3

During the past 4 weeks have you had any of the following problems with your work or other regular daily activities
as a result of your physical health?
YES
1
1

4. Accomplished less than you would like.
5. Were limited in the kind of work or other activities.

NO
2
2

During the past 4 weeks, have you had any of the following problems with your work or other regular daily activities
as a result of any emotional problems (such as feeling depressed or anxious)?
YES
1
1

6. Accomplished less than you would like.
7. Didn’t do work or other activities as carefully as usual.
8.

NO
2
2

During the past 4 weeks, how much did pain interfere with your normal work (including both work outside the
home and housework)?
Not at All
(1)

A little bit
(2)

Moderately
(3)

Quite a bit
(4)

Extremely
(5)

These questions are about how you feel and how things have been with you during the past 4 weeks. For each
question, please give the one answer that comes closest to the way you have been feeling. How much of the time
during the past 4 weeks?

9. Have you felt calm and peaceful?
10. Did you have a lot of energy?
11. Have you felt downhearted and blue?

All of the
time
1
1
1

Most of
the time
2
2
2

A good bit
of the time
3
3
3

Some of
the time
4
4
4

A little of
the time
5
5
5

None of
the time
6
6
6

12. During the past 4 weeks, how much of the time has your physical health or emotional problems interfered with
your social activities (like visiting with friends, relatives, etc)?
All of the time
(1)

Version: 25-May-2017

Most of the time
(2)

Some of the time
(3)

A little of the time None of the time
(4)
(5)
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Appendix F: Western Ontario and McMaster Universities Osteoarthritis Index
(WOMAC)

Collared vs Collarless RCT

Study ID: ___________
Date: _______________
WOMAC

A. Think about the pain you felt in your hip/knee during the last 48 hours.
Question: How much pain do you have?
1. Walking on a flat surface
2. Going up or down stairs
3. At night while in bed, pain disturbs your
sleep
4. Sitting or lying
5. Standing upright

None
0
0
0

Mild
1
1
1

Moderate
2
2
2

Severe
3
3
3

Extreme
4
4
4

0
0

1
1

2
2

3
3

4
4

B. Think about the stiffness (not pain) you felt in your hip/knee during the last 48 hours. Stiffness is a
sensation of decreased ease in moving your joint.
6. How severe is your stiffness after first
awakening in the morning?
7. How severe is your stiffness after sitting,
lying, or resting later in the day?

None
0

Mild
1

Moderate
2

Severe
3

Extreme
4

0

1

2

3

4

C. Think about the difficulty you had in doing the following daily physical activities dues to your
hip/knee during the last 48 hours. By this we mean your ability to move around and look after
yourself.
Question: What degree of difficulty do you
have?
8. Descending stairs
9. Ascending stairs
10. Rising from sitting
11. Standing
12. Bending to the floor
13. Walking on a flat surface
14. Getting in and out of a car, or on or off a
bus
15. Going shopping
16. Putting on your socks or stockings
17. Rising from bed
18. Taking off your socks or stockings
19. Lying in bed
20. Getting in or out of the bath
21. Sitting
22. Getting on or off the toilet
23. Performing heavy domestic duties
24. Performing light domestic duties

Version: 25-May-2017

None

Mild

Moderate

Severe

Extreme

0
0
0
0
0
0
0

1
1
1
1
1
1
1

2
2
2
2
2
2
2

3
3
3
3
3
3
3

4
4
4
4
4
4
4

0
0
0
0
0
0
0
0
0
0

1
1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3
3
3

4
4
4
4
4
4
4
4
4
4

84

Appendix G: University of California, Los Angeles (UCLA) Activity Score

Collared vs Collarless RCT

Study ID: ___________
Date: _______________
UCLA Activity Score

Check one box that best describes current activity level.
⃝

1: Wholly Inactive, dependent on others, and can not leave residence

⃝

2: Mostly Inactive or restricted to minimum activities of daily living

⃝

3: Sometimes participates in mild activities, such as walking, limited housework and limited shopping

⃝

4: Regularly Participates in mild activities

⃝

5: Sometimes participates in moderate activities such as swimming or could do unlimited housework or shopping

⃝

6: Regularly participates in moderate activities

⃝

7: Regularly participates in active events such as bicycling

⃝

8: Regularly participates in active events, such as golf or bowling

⃝

9: Sometimes participates in impact sports such as jogging, tennis, skiing, acrobatics, ballet, heavy labor or backpacking

⃝

10: Regularly participates in impact sports

Version: 25-May-2017
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Appendix H: Harris Hip Score (HHS)

Collared vs Collarless RCT

Study ID: ___________
Date: _______________
Harris Hip Score
FUNCTION – FUNCTIONAL ACTIVITIES (STAIRS)

PAIN
None/ignores

44

Normally

4

Slight, occasional, no compromise in activity

40

Normally with banister

2

Mild, No effect on ordinary activity, pain
after unusual activity, uses aspirin

30

Any method

1

Not able

0

Moderate, tolerable, makes concessions,
occasional codeine

20

Marked, serious limitations

10

Totally disabled

0

FUNCTION – GAIT (LIMP)

FUNCTION – FUNCTIONAL ACTIVITIES
(SOCKS/TIE SHOES)
With ease

4

With difficulty

2

Unable

0

None

11

Slight

8

FUNCTION – FUNCTIONAL ACTIVITIES (SITTING)

Moderate

5

Any chair, 1 hour

5

Severe

0

High chair, ½ hour

3

Unable

0

FUNCTION – GAIT (SUPPORT)
None

11

Cane, long walks

7

Cane, full time

5

Enter public transport/Car

1

Crutch

4

Not able to use public transport

0

2 canes

2

Unable to walk/2 crutches

0

FUNCTION – GAIT (DISTANCE WALKED)
Unlimited

11

6 blocks (1hour)

8

2-3 blocks (½ hour)

5

Indoors only/Less than 1 block
Bed and chair

Version: 29-May-2017

FUNCTION – FUNCTIONAL ACTIVITIES
(TRANSPORT)

ABSENCE OF DEFORMITY
None

4

Fixed ADD>10° OR Fixed IRE>10° OR Leg
length discrepancy >3cm OR PFC >30°

0

RANGE OF MOTION

2

Flexion 90°

1

0

Abduction 30°

1

Adduction 20°

1

External Rotation 20°

1

Internal Rotation 15°

1
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Appendix I: Charlson Commorbidity Index

Collared vs Collarless RCT

Study ID: ___________
Date: _______________
Charlson Comorbidity Index

Assigned weighting
for diseases
1

Client’s
weighting

Conditions
Myocardial infarct
Congestive cardiac insufficiency
Peripheral vascular disease
Dementia
Cerebrovascular disease
Chronic pulmonary disease
Conjunctive/connective tissue disease
Slight diabetes, without complications
Ulcers
Chronic diseases of the liver or cirrhosis
None

SUBTOTAL: __________
2

Hemiplegia
Moderate or severe kidney disease
Diabetes with complications
Tumors
Leukaemia
Lymphoma
None
SUBTOTAL: __________

3

Moderate or severe liver disease
None
SUBTOTAL: __________

4

Malignant tumor, metastasis
AIDS
None
SUBTOTAL: __________
TOTAL WEIGHTING: __________

Version: 25-May-2017
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